21268 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Copolymer-stabilized emulsions
#2102AGENT FOR CONTROL OF DEGRANULATION REACTION AND CYTOKINE PRODUCTION
#2103INTRASYNOVIAL FORMULATIONS OF STANOZOLOL
#2104COMPOSITIONS FORMULATED FOR SOLVENT-REGULATED DRUG RELEASE
#2105RECOMBINANT VWF FORMULATIONS
#2106NOVEL TOPICAL FORMULATIONS FOR IMPROVING THE APPEARANCE OF NAILS
#2107Transdermal drug delivery devices having coated microprotrusions
#2108METHOD FOR STABILIZATION OF ISOXAZOLE COMPOUND
#2109Stabilised compositions of factor VII polypeptides
#2110PHARMACEUTICAL COMPOUND TO PREVENT AND TREAT FOCAL TISSULAR LESIONS AND INFECTIONS, METHOD AND APPLICATORS
#2111Compositions and methods for enhancing corticosteroid delivery
#2112Dermal medicament delivery system
#2113Transdermally absorbable Donepezil Preparation
#2114Human Antibodies That Bind Human IL-12 And Methods For Producing
#2115METHODS FOR TREATMENT OF INFLAMMATORY DISEASES
#2116Liquid antiseptic compositions containing iodine and a sugar and/or sugar alcohol
#2117Aqueous gel formulations containing immune response modifiers
#2118PHARMACEUTICALS CONTAINING FLUOROQUINOLONES
#2119AGGREGATES WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN
#2120Reduced dose intravenous acetaminophen
#2121Drug conjugate composition
#2122Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate
#2123Dry powder inhalation system for transpulmonary administration
#2124Compositions comprising an active agent
#2125DEPSIPEPTIDE-CONTAINING INJECTION SOLUTION
#2126Dry powder inhalation system for transpulmonary administration
#2127Intranasal anti-convulsive compositions and methods
#2128Pharmaceutical composition containing gelling agent
#2129Stabilised Solid Composition of Modified Factor VII
#2130Stable cleanser compositions containing sulfur
#2131Use of a virucidal ointment in the nares for prevention of transmission and contraction of common colds
#2132NSAID FORMULATIONS, BASED ON HIGHLY ADAPTABLE AGGREGATES, FOR IMPROVED TRANSPORT THROUGH BARRIERS AND TOPICAL DRUG DELIVERY
#2133NSAID FORMULATIONS, BASED ON HIGHLY ADAPTABLE AGGREGATES, FOR IMPROVED TRANSPORT THROUGH BARRIERS AND TOPICAL DRUG DELIVERY
#2134Anti-IL-13 antibody formulations and uses thereof
#2135Composition
#2136Methods of therapy using pharmaceutical composition for thrombin peptide derivatives
#2137NSAID FORMULATIONS, BASED ON HIGHLY ADAPTABLE AGGREGATES, FOR IMPROVED TRANSPORT THROUGH BARRIERS AND TOPICAL DRUG DELIVERY
#2138Compositions of specific binding agents to hepatocyte growth factor
#2139Aqueous oral solution of bisphosphonic acid
#2140Transdermal Drug Delivery Formulation
#2141Reversibly inactivated acidified plasmin
#2142Combinations Comprising a Vegf Receptor Inhibitor
#2143HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#2144Diclofenac topical formulation
#2145Alcohol free formulation of argatroban
#2146Topical preparation and method for transdermal delivery and localization of therapeutic agents
#2147Stabilized FGF formulations containing reducing agents
#2148Pharmaceutical composition comprising 5-methyl-2 (2'-chloro-6'-fluoroanillino) phen ylacetic acid
#2149Presentation of an antiviral pharmaceutical composition
#2150PHARMACEUTICAL COMPOSITIONS COMPRISING A POORLY WATER-SOLUBLE ACTIVE INGREDIENT, A SURFACTANT AND A WATER-SOLUBLE POLYMER
#2151Compositions and Methods for Treating Burns
#2152ALLANTOIN-CONTAINING SKIN CREAM
#2153Oral solid preparation and method of manufacturing the same
#2154Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
#2155Suspension formulations of insulinotropic peptides and uses thereof
#2156Stabilized anthocyanin compositions
#2157Aqueous Solution Preparation Containing Camptothecins
#2158TRANSDERMAL COMPOSITION HAVING ENHANCED COLOR STABILITY
#2159Liquid composition of factor VII polypeptides
#2160Prevention of hydrogel viscosity loss
#2161TOPICAL FORMULATION
#2162Composition Containing Micronutrients With Improved Anti-Oxidant Activity And The Use Thereof
#2163Intracorporeal medicaments for photodynamic treatment of disease
#2164Topical Ungual Formulations
#2165Closed container comprising an activated factor VII polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
#2166Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent
#2167OXYGEN-CARRYING BLOOD SUBSTITUTE PREPARATIONS
#2168Method and Composition For Use In Preparation of a Patient For Surgery
#2169Nanoparticulate megestrol formulations
#2170Pharmaceutical compositions and method for treating inflammation in cattle and other animals
#2171Composition comprising pyrithione or a polyvalent metal salt of a pyrithione and furametpyr
#2172Cosmetic and pharmaceutical foam
#2173Compositions for treatment of viral-induced skin lesions and methods of using same
#2174Enhanced immediate release formulations of topiramate
#2175NEW APORPHINE ESTERS AND THEIR USE IN THERAPY
#2176Liquid adenovirus formulations
#2177Formulation for adenovirus storage
#2178Parenteral Forms Of Administration Of Imexon And Method For The Production Thereof
#2179DNA DOSAGE FORMS
#2180Formulations of sitaxsentan sodium
#2181Allantoin-containing skin cream
#2182Methods of increasing oral bioavailability of tetracyclines
#2183Methods for reducing protein aggregation
#2184COMPOSITIONS FOR CLEANING AND DISINFECTING NASAL TRACT AND SINUS CAVITY
#2185Disinfecting Composition and Methods of Making and Using Same
#2186Combination/association of adapalene and benzoyl peroxide for treating acne lesions
#2187Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disorders
#2188Antimicrobial compositions and methods for their use
#2189METHOD FOR REDUCING PAIN
#2190Pharmaceutical formulation comprising ziconotide
#2191Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
#2192Water dispersible films for delivery of active agents to the epidermis
#2193Ozonidzed Pharmaceutical Composition and Method
#2194Compositions and kits useful for treatment of respiratory illness
#2195ABSORPTION ENHANCING AGENTS
#2196Compositons and methods for maintaining eyelid hygiene
#2197Pharmaceutical Compositions
#2198Conjugated fatty acid based emulsion and methods for preparing and using same
#2199Stabilised solid compositions of factor VII polypeptides
#2200Stabilized compositions of proteins having a free thiol moiety
#2201Megestrol acetate suspension
#2202Compositions and Methods for the Direct Therapy of Tumors
#2203Pharmaceutical composition comprising an active principal and sulphobetaine
#2204Prolonged release bioadhesive therapeutic systems
#2205Compositions comprising vitamins and/or derivatives thereof stablished with olea europea extract and/or ionene polymers
#2206Compositions and methods for enhancing corticosteroid delivery
#2207Compositions and methods for enhancing corticosteroid delivery
#2208Injectable compositions for the controlled delivery of pharmacologically active compound
#2209Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
#2210Pharmaceutical composition comprising 5-methyl-2(2'-chloro-6'-fluoroanilino)phenylacetic acid
#2211Method of improving suitability for granulation
#2212Immunoglobulin preparations having increased stability
#2213Stabilized interferon liquid formulations
#2214Therapeutic foam
#2215Water-Soluble Aspirin Composition
#2216Stabilized liquid protein formulations in pharmaceutical containers
#2217Intracorporeal medicaments for high energy phototherapeutic treatment of disease
#2218Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
#2219Transdermal hormone delivery system: compositions and methods
#2220Novel Dry Powder Inhalation System For Transpulmonary Administration
#2221Human serum albumin-free stabilized interferon liquid formulations
#2222Pharmaceutical formulations
#2223Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
#2224Prevention and treatment of ophthalmic complications of diabetes
#2225Stabilised compositions of Factor VII
#2226Preparations and processes for stabilizing biological materials by means of drying processes without freezing
#2227Formulations of fenofibrate containing PEG/Poloxamer
#2228Formulations of fenofibrate containing menthol
#2229Intracorporeal medicaments for photodynamic treatment of disease
#2230Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
#2231Drug conjugate composition
#2232Drug conjugate composition
#2233Drug conjugate composition
#2234Therapeutic foam
#2235Methods of preparing a foam comprising a sclerosing agent
#2236Personal care and medicinal products incorporating bound organosulfur groups
#2237Directly injectable formulations which provide enhanced cryoprotection of cell products
#2238Pharmaceutical compositions containing camptothecins
#2239Sustained release of microcrystalline peptide suspensions
#2240Sustained release of microcrystalline peptide suspensions
#2241DNA vaccine formulations
#2242Stabilized liquid polypeptide formulations
#2243Liquid, aqueous pharmaceutical compositions of factor VII polypeptides
#2244Topical medicaments and methods for photodynamic treatment of disease
#2245Stabilized, solid-state polypeptide particles
#2246Solvent/polymer solutions as suspension vehicles
#2247Anti Aβ antibody formulation
#2248Liquid composition of factor VII polypeptides
#2249Peptides having a high cysteine content
#2250Use of a polypeptide for treatment of pruritus in animals
#2251Ocular irrigating solution
#2252Liquid, aqueous pharmaceutical composition of Factor VII polypeptides
#2253Nanoparticulate candesartan formulations
#2254Glycyrrhizin high-concentration preparation
#2255Skin lightening composition
#2256Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
#2257Cosmetic and pharmaceutical foam
#2258Methods for treatment of inflammatory diseases
#2259Stable cleanser compositions containing sulfur
#2260Stable cleanser compositions containing sulfur
#2261Allantoin-containing skin cream
#2262Stabilized liquid polypeptide-containing pharmaceutical compositions
#2263Stabilized liquid polypeptide-containing pharmaceutical compositions
#2264Surface modified viscoelastics for ocular surgery
#2265Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins
#2266Dry powder inhalation system for transpulmonary administration
#2267Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
#2268Inhibitors of decrease in body temperature
#2269Therapeutic foam
#2270Stabilized aqueous preparation for injection
#2271Compositions suitable for controlled release of the hormone GnRH and its analogs
#2272Aqueous pharmaceutical formulaton comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism
#2273Transdermal drug delivery formulations with optimal amounts of vasodilators therein
#2274Freeze-dried preparation of stabilized anthracycline compound
#2275Stable cleanser compositions containing sulfur
#2276Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
#2277Intracorporeal medicaments for photodynamic treatment of disease
#2278Method and pharmaceutical to treat spinal discs
#2279Compositions and methods for treating burns
#2280Methods and compositions for preventing oxidative degradation of proteins
#2281Compounds and compositions for delivering active agents
#2282Therapeutic antimicrobial compositions and methods
#2283Body cavity foams
#2284Apparatus and method for transdermal delivery of parathyroid hormone agents
#2285Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration
#2286Use of targeted oxidative therapeutic formulation in bone regeneration
#2287Method of using secretin and compositions made therefrom for the treatment of autism and other neurological, behavioral and immunological disorders
#2288Stable injectable compositions
#2289Nanoparticulate megestrol formulations
#2290Stabilized protein compositions
#2291Stabilized albumin preparations
#2292Compositions with reduced hepatotoxicity
#2293Apparatus and method for transdermal delivery of influenza vaccine
#2294Compositions and methods for maintaining eyelid hygiene
#2295Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants
#2296Prolonged release bioadhesive therapeutic systems
#2297Pharmaceutical composition for thrombin peptide derivatives
#2298Method for reducing pain
#2299Compounds and compositions for delivering active agents
#2300Stable parenteral formulation of levomepromazine and a method for stabilizing said formulation
#2301Pharmaceutical preparation comprising an antibody against the EGF receptor
#2302Formulation of adenovirus for gene therapy
#2303Injectable compositions for the controlled delivery of pharmacologically active compound
#2304Intracorporeal medicaments for photodynamic treatment of disease
#2305Method for administering glp-1 molecules
#2306Compositions comprising an active agent
#2307Aporphine esters and their use in therapy
#2308Composition with stabilized redox properties and method of stabilization of redox properties
#2309Hybrid system for solubilizing pharmaceutically active substances in polymer matrices
#2310Supersaturated aqueous ifosfamide compositions
#2311Topical compositions containing tea tree oil for treatment of viral lesions
#2312Compounds and compositions for delivering active agents
#2313Medicinal composition
#2314Psoriasis formulation and method of preparation
#2315Treatment of cancers with methylol-containing compounds and at least one electrolyte
#2316Medicinal composition
#2317Antimicrobial compositions and methods
#2318Delivery of biologically active agents
#2319Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
#2320Dna dosage forms
#2321Dna dosage forms
#2322Injectable compositions for the controlled delivery of pharmacologically active compound
#2323Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
#2324Antimicrobial compositions and methods
#2325Atopic dermatitis treatment method
#2326Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
#2327Weight reduction or weight controlling composition
#2328Injectable composition of paclitaxel
#232917Afla,21-dihydroxypregnene esters as antiandrogenic agents
#2330Single dose fast dissolving azithromycin
#2331Chemical combination and method for increasing delivery of Coenzyme Q10
#2332Sincalide formulations
#2333Formulation strategies in stabilizing peptides in organic solvents and in dried states
#2334Nanoparticulate megestrol formulations
#2335Topical use of cytokines and chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
#2336Human antibodies that bind human IL-12
#2337Atomoxetine hydrochloride oral suspension and use thereof
#2338Atomoxetine hydrochloride oral suspension and use thereof
#2339Dissolving microneedle containing cannabidiol suspension and preparation method thereof
#2340Kit and new method of treatment for skin basal cell and squamous cell carcinoma
#2341Method of lubricating bodily tissue using an amnion derived therapeutic composition
#2342Stable pharmaceutical formulation
#2343Cannabinoids based pharmaceutical composition
#2344Topical treatment of herpes infections
#2345Hyaluronic acid formulation
#2346Herbal formulations of carnivorous plants and methods for treating inflammation
#2347Massage and sport cream composition systems
#2348Topical skin health improvement compositions and administrations thereof
#2349Solid oral formulations having an iron sugar overcoat
#2350Method of treating opiate dependency using tetrahydrocannabinol extracts
#2351Composition(s) and method(s) for topically treating pain